As of 2024-12-12, the EV/EBITDA ratio of United Therapeutics Corp (UTHR) is 10.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. UTHR's latest enterprise value is 15,012.92 mil USD. UTHR's TTM EBITDA according to its financial statements is 1,422.90 mil USD. Dividing these 2 quantities gives us the above UTHR EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 16.9x | 15.0x |
| Forward P/E multiples | 15.8x - 22.5x | 16.3x |
| Fair Price | 440.86 - 776.35 | 535.72 |
| Upside | 21.7% - 114.4% | 47.9% |
| Date | EV/EBITDA |
| 2024-12-12 | 10.57 |
| 2024-12-11 | 10.55 |
| 2024-12-10 | 10.55 |
| 2024-12-09 | 10.70 |
| 2024-12-06 | 10.79 |
| 2024-12-05 | 10.93 |
| 2024-12-04 | 10.93 |
| 2024-12-03 | 10.76 |
| 2024-12-02 | 10.80 |
| 2024-11-29 | 10.81 |
| 2024-11-27 | 11.05 |
| 2024-11-26 | 11.02 |
| 2024-11-25 | 10.75 |
| 2024-11-22 | 10.89 |
| 2024-11-21 | 10.71 |
| 2024-11-20 | 10.62 |
| 2024-11-19 | 10.51 |
| 2024-11-18 | 10.46 |
| 2024-11-15 | 10.59 |
| 2024-11-14 | 11.31 |
| 2024-11-13 | 11.75 |
| 2024-11-12 | 11.77 |
| 2024-11-11 | 11.75 |
| 2024-11-08 | 12.05 |
| 2024-11-07 | 11.82 |
| 2024-11-06 | 11.66 |
| 2024-11-05 | 11.20 |
| 2024-11-04 | 11.01 |
| 2024-11-01 | 10.92 |
| 2024-10-31 | 10.92 |
| 2024-10-30 | 10.53 |
| 2024-10-29 | 10.26 |
| 2024-10-28 | 10.16 |
| 2024-10-25 | 10.13 |
| 2024-10-24 | 10.18 |
| 2024-10-23 | 10.25 |
| 2024-10-22 | 10.81 |
| 2024-10-21 | 10.82 |
| 2024-10-18 | 10.75 |
| 2024-10-17 | 10.89 |
| 2024-10-16 | 10.80 |
| 2024-10-15 | 10.47 |
| 2024-10-14 | 10.39 |
| 2024-10-11 | 10.43 |
| 2024-10-10 | 10.31 |
| 2024-10-09 | 10.38 |
| 2024-10-08 | 10.35 |
| 2024-10-07 | 10.16 |
| 2024-10-04 | 10.36 |
| 2024-10-03 | 10.17 |